1,796
Views
10
CrossRef citations to date
0
Altmetric
Research Article

The impact of ultrasound-guided high-intensity focused ultrasound for uterine fibroids on ovarian reserve

, , , , , , , & show all
Pages 399-403 | Received 30 Dec 2019, Accepted 03 Apr 2020, Published online: 28 Apr 2020

References

  • Hervé F, Katty A, Isabelle Q, et al. Impact of uterine fibroids on quality of life: a national cross-sectional survey. Eur J Obstet Gynecol Reprod Biol. 2018;229:32–37.
  • Borah BJ, Nicholson WK, Bradley L, et al. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol. 2013;209(4):319.e1–e20.
  • He M, Jacobson H, Zhang C, et al. A retrospective study of ultrasound-guided high intensity focused ultrasound ablation for multiple uterine fibroids in South Africa. Int J Hyperthermia 2018;34(8):1304–1310.
  • Park J, Lee JS, Cho JH, et al. Effects of high-intensity focused ultrasound treatment on benign uterine tumor. J Korean Med Sci. 2016;31(8):1279–1283.
  • Chen R, Keserci B, Bi H, et al. The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China. J Ther Ultrasound. 2016;4:27.
  • Zhao WP, Zhang J, Han ZY, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound. Sci Rep. 2017;7(1):10812.
  • Zhang C, Jacobson H, Ngobese ZE, et al. Efficacy and safety of ultrasound-guided high intensity focused ultrasound ablation of symptomatic uterine fibroids in Black women: a preliminary study. Int J Obstet Gyenecol. 2017;124 (Suppl 3):12–17.
  • Ji Y, Hu K, Zhang Y, et al. High intensity focused ultrasound (HIFU) treatment for uterine fibroids: a meta-analysis. Arch Gynecol Obstet. 2017;296(6):1181–1188.
  • Liu Y, Zhang WW, He M, et al. Adverse effect analysis of high-intensity focused ultrasound in the treatment of benign uterine diseases. Int J Hyperthermia 2018;35(1):56–61.
  • Chen J, Chen W, Zhang L, et al. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: a review of 9988 cases. Ultrason Sonochem. 2015;27:671–676.
  • Wang HY, Quan S, Zhang RL, et al. Comparison of serum anti-Mullerian hormone levels following hysterectomy and myomectomy for benign gynaecological conditions. Eur J Obstet Gynecol Reprod Biol. 2013;171(2):368–371.
  • Gökgözoğlu L, Islimye M, Topçu HO, et al. The effects of total abdominal hysterectomy on ovarian function - Serial changes in serum anti-Müllerian hormone, FSH and estradiol levels. Adv Clin Exp Med. 2014;23(5):821–825.
  • Yuan H, Wang C, Wang D, et al. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: A prospective cohort study. J Minim Invasive Gynecol. 2015;22(4):637–641.
  • Ouyang Z, Liu P, Yu Y, et al. Role of ovarian artery-to-uterine artery anastomosis in uterine artery embolization: Initial anatomic and radiologic studies. Surg Radiol Anat. 2012;34(8):737–741.
  • Ryu RK, Chrisman HB, Omary RA, et al. The vascular impact of uterine artery embolization: Prospective sonographic assessment of ovarian arterial circulation. J Vasc Interv Radiol. 2001;12(9):1071–1074.
  • Kim CW, Shim HS, Jang H, Song YG. The effects of uterine artery embolization on ovarian reserve. Eur J Obstet Gynecol Reprod Biol. 2016;206:172–176.
  • Arthur R, Kachura J, Liu G, et al. Laparoscopic myomectomy versus uterine artery embolization: Long-term impact on markers of ovarian reserve. J Obstet Gynaecol Can. 2014;36(3):240–247.
  • Cheung VY, Lam TP, Jenkins CR, et al. Ovarian reserve after ultrasound-guided high intensity focused ultrasound for uterine fibroids: preliminary experience. J Obstet Gynaecol Can. 2016;38(4):357–361.
  • Lee JS, Hong GY, Lee KH, et al. Changes in anti-müllerian hormone levels as a biomarker for ovarian reserve after ultrasound-guided high- intensity focused ultrasound treatment of adenomyosis and uterine fibroid. BJOG: Int J Obstet Gynecol. 2017;124 (Suppl 3):18–22.
  • Faddy MJ, Gosden RG, Gougeon A, et al. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7(10):1342–1346.
  • Tehrani FR, Mansournia MA, Solaymani-Dodaran M, et al. Age-specific serum anti-Müllerian hormone levels: estimates from a large population-based sample. Climacteric 2014;17(5):591–597.